R1 Announces Grants of Inducement Equity Awards in Connection with the Acquisition of Cloudmed
MURRAY, Utah, June 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, today announced that it has granted equity awards under the R1 RCM Inc. 2022 Inducement Plan (the Inducement Plan) in connection with its acquisition of Cloudmed, which closed today.
- MURRAY, Utah, June 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, today announced that it has granted equity awards under the R1 RCM Inc. 2022 Inducement Plan (the Inducement Plan) in connection with its acquisition of Cloudmed, which closed today.
- R1 granted an award of 151,286 extended-vesting performance-based restricted stock units (PBRSUs) to Lee Rivas, R1s newly appointed President.
- R1 also granted inducement awards under the Inducement Plan to 123 other employees of Cloudmed consisting of (i) an aggregate of 2,895,826 standard-vesting PBRSUs and extended-vesting PBRSUs to 121 employees and (ii) 126,072 restricted stock units (RSUs) to two employees.
- The PBRSU and RSU awards were approved by the Human Capital Committee and by the Board of Directors of R1 and were granted under the Inducement Plan in accordance with NASDAQ Listing Rule 5635(c)(4), as inducement awards material to Mr. Rivas and the other Cloudmed employees entering employment with R1.